dihexa lipophilic peptidomimetic Peptidomimetics based on thiacalixarene with L-tyrosine moieties: Antibacterial activity against methicillin-resistant Staphylococcus aureus and degradation induced by binding to α-chymotrypsin Full article: Design of peptidomimetic

Additional studies have examined GHK-Cu's effects on skin thickness, elasticity markers, and photoaging models in research settings

Peptide therapy is not appropriate during pregnancy or breastfeeding, in active or recent cancer, in some autoimmune conditions, or for patients on certain medications

SIRT1 enhances synaptic formation and synaptic activity, and therefore, can reduce the progression of various degenerative brain diseases including Parkinsons disease (PD)

Currently, no company worldwide has completed the required oral toxicity studies, metabolism studies, and long-term safety evaluations for GHK-Cu and submitted a GRAS notification to the FDA

Some protocols recommend even lower starting doses around 0.05 mg (50 mcg) for particularly sensitive individuals, though most users find 0.1 mg an appropriate beginning point

Despite its light and gentle formula, the product effectively regenerates the skin, providing it with essential active ingredients